Pluristem's PLX cells perform well in tendon injures in rats


Pluristem's (PSTI +2%) PLacental eXpanded (PLX) cells produce positive results in pre-clinical trials of rats with tendon injuries.

"PLX-treated tendons demonstrated better early structural properties at two and four weeks compared to saline-treated controls," Pluristem says.

"As an 'off the shelf' cell source, PLX cells could provide an effective option to improve tendon healing," says Dr Scott Rodeo, the Principal Investigator for the study.

PLX is undergoing a Phase I/II clinical trial in Germany to test it in muscle injuries. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs